Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients

Anecdotal reports have attributed persistent splenomegaly in African sickle cell anemia (SS) patients to the effects of malaria. However, no comparative studies of patients in malarial and nonmalarial regions have been conducted, and few studies of malaria antibody titers have been reported. In the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hematology 1993-03, Vol.42 (3), p.316-321
Hauptverfasser: Adekile, A. D., McKie, K. M., Adeodu, O. O., Sulzer, A. J., Liu, J.‐S., McKie, V. C., Kutlar, F., Ramachandran, M., Kaine, W., Akenzua, G. I., Okolo, A. A., Asindi, A. A., Obinyan, E. A., Ogala, W. N., Ibrahim, M., Huisman, T. H. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 321
container_issue 3
container_start_page 316
container_title American journal of hematology
container_volume 42
creator Adekile, A. D.
McKie, K. M.
Adeodu, O. O.
Sulzer, A. J.
Liu, J.‐S.
McKie, V. C.
Kutlar, F.
Ramachandran, M.
Kaine, W.
Akenzua, G. I.
Okolo, A. A.
Asindi, A. A.
Obinyan, E. A.
Ogala, W. N.
Ibrahim, M.
Huisman, T. H. J.
description Anecdotal reports have attributed persistent splenomegaly in African sickle cell anemia (SS) patients to the effects of malaria. However, no comparative studies of patients in malarial and nonmalarial regions have been conducted, and few studies of malaria antibody titers have been reported. In the present study, age‐ and sex‐matched Nigerian and U.S. steady‐state SS patients were compared. Splenomegaly was found in 22.3% of Nigerian patients (n = 310), while it was found only in 8% of U.S. patients (n = 100) from Georgia. There was significant linear correlation between spleen size and Hb levels and with serum immunoglobulins in the Nigerian group. However, serum complement levels (C3 and C4) were not affected by spleen size. In both groups, patients with splenomegaly had fewer circulating pitted red cells than their counterparts without splenomegaly. The mean ± SE of IgG‐specific malaria antibody titer among the Nigerian patients without palpable spleens was 9,386 ± 2,036; 9,334 ± 2,980 in those with spleens between 1 and 5 cm, 16,201 ± 4,502 in those with spleens between 6 and 10 cm, and 22,445 ± 8,456 in those with spleens above 10 cm. Coexistent α‐thalassemia did not influence the prevalence of splenomegaly among the Nigerian SS patients. This study provides additional evidence that malaria plays a significant role in the persistence of splenomegaly in African patients. © 1993 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ajh.2830420313
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75619307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75619307</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2843-b224996944312b6d471b6387f7dcdce458c5a0bc970a9d535588fe7fd6fedfc33</originalsourceid><addsrcrecordid>eNqFkDtvGzEQhAnDhiM_2nQBWBjpdOH7SHeCkNgxBKuQVR945DKhcy8fpRj696EgwXaXahfYb2cGg9BnSgpKCPtmn38XTHMiGOGUn6AJJUZNtZLsFE0IVzTvxHxCFyk9E0Kp0OQcnWvBtSFygparoQHocOxwiu5PA9hB02DbQRvtLZ737WBHu4l_AafN1kdIuA_4Mf6CMdoucx6vi1WBh8xAt0lX6CzYJsH1cV6i9Y_vT_P76WJ593M-W0wdy97TmjFhjDJCcMpq5UVJa8V1GUrvvAMhtZOW1M6UxBovuZRaByiDVwF8cJxfoq8H3WHsX7aQNlUb0z56Tt5vU1VKRQ0nZQaLA-jGPqURQjWMsbXjrqKk2jdY5Qar9wbzw5ej8rZuwb_hx8ry_eZ4t8nZJoy2czG9YUIxaeRexhyw19jA7j-m1ezh_kOEf8BOiDU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75619307</pqid></control><display><type>article</type><title>Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Adekile, A. D. ; McKie, K. M. ; Adeodu, O. O. ; Sulzer, A. J. ; Liu, J.‐S. ; McKie, V. C. ; Kutlar, F. ; Ramachandran, M. ; Kaine, W. ; Akenzua, G. I. ; Okolo, A. A. ; Asindi, A. A. ; Obinyan, E. A. ; Ogala, W. N. ; Ibrahim, M. ; Huisman, T. H. J.</creator><creatorcontrib>Adekile, A. D. ; McKie, K. M. ; Adeodu, O. O. ; Sulzer, A. J. ; Liu, J.‐S. ; McKie, V. C. ; Kutlar, F. ; Ramachandran, M. ; Kaine, W. ; Akenzua, G. I. ; Okolo, A. A. ; Asindi, A. A. ; Obinyan, E. A. ; Ogala, W. N. ; Ibrahim, M. ; Huisman, T. H. J.</creatorcontrib><description>Anecdotal reports have attributed persistent splenomegaly in African sickle cell anemia (SS) patients to the effects of malaria. However, no comparative studies of patients in malarial and nonmalarial regions have been conducted, and few studies of malaria antibody titers have been reported. In the present study, age‐ and sex‐matched Nigerian and U.S. steady‐state SS patients were compared. Splenomegaly was found in 22.3% of Nigerian patients (n = 310), while it was found only in 8% of U.S. patients (n = 100) from Georgia. There was significant linear correlation between spleen size and Hb levels and with serum immunoglobulins in the Nigerian group. However, serum complement levels (C3 and C4) were not affected by spleen size. In both groups, patients with splenomegaly had fewer circulating pitted red cells than their counterparts without splenomegaly. The mean ± SE of IgG‐specific malaria antibody titer among the Nigerian patients without palpable spleens was 9,386 ± 2,036; 9,334 ± 2,980 in those with spleens between 1 and 5 cm, 16,201 ± 4,502 in those with spleens between 6 and 10 cm, and 22,445 ± 8,456 in those with spleens above 10 cm. Coexistent α‐thalassemia did not influence the prevalence of splenomegaly among the Nigerian SS patients. This study provides additional evidence that malaria plays a significant role in the persistence of splenomegaly in African patients. © 1993 Wiley‐Liss, Inc.</description><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.2830420313</identifier><identifier>PMID: 8438905</identifier><identifier>CODEN: AJHEDD</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Adult ; African SS patients ; alpha-Thalassemia - genetics ; Anemia, Sickle Cell - epidemiology ; Anemias. Hemoglobinopathies ; Antibodies, Protozoan - blood ; Biological and medical sciences ; Child ; Child, Preschool ; Chromosome Mapping ; Complement System Proteins - analysis ; Diseases of red blood cells ; Erythrocyte Count ; Female ; Georgia - epidemiology ; Globins - genetics ; Hematologic and hematopoietic diseases ; Humans ; Immunoglobulins - blood ; Infant ; malaria ; Malaria - immunology ; Male ; Medical sciences ; Nigeria - epidemiology ; splenomegaly ; Splenomegaly - epidemiology</subject><ispartof>American journal of hematology, 1993-03, Vol.42 (3), p.316-321</ispartof><rights>Copyright © 1993 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2843-b224996944312b6d471b6387f7dcdce458c5a0bc970a9d535588fe7fd6fedfc33</citedby><cites>FETCH-LOGICAL-c2843-b224996944312b6d471b6387f7dcdce458c5a0bc970a9d535588fe7fd6fedfc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.2830420313$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.2830420313$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4625953$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8438905$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adekile, A. D.</creatorcontrib><creatorcontrib>McKie, K. M.</creatorcontrib><creatorcontrib>Adeodu, O. O.</creatorcontrib><creatorcontrib>Sulzer, A. J.</creatorcontrib><creatorcontrib>Liu, J.‐S.</creatorcontrib><creatorcontrib>McKie, V. C.</creatorcontrib><creatorcontrib>Kutlar, F.</creatorcontrib><creatorcontrib>Ramachandran, M.</creatorcontrib><creatorcontrib>Kaine, W.</creatorcontrib><creatorcontrib>Akenzua, G. I.</creatorcontrib><creatorcontrib>Okolo, A. A.</creatorcontrib><creatorcontrib>Asindi, A. A.</creatorcontrib><creatorcontrib>Obinyan, E. A.</creatorcontrib><creatorcontrib>Ogala, W. N.</creatorcontrib><creatorcontrib>Ibrahim, M.</creatorcontrib><creatorcontrib>Huisman, T. H. J.</creatorcontrib><title>Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><description>Anecdotal reports have attributed persistent splenomegaly in African sickle cell anemia (SS) patients to the effects of malaria. However, no comparative studies of patients in malarial and nonmalarial regions have been conducted, and few studies of malaria antibody titers have been reported. In the present study, age‐ and sex‐matched Nigerian and U.S. steady‐state SS patients were compared. Splenomegaly was found in 22.3% of Nigerian patients (n = 310), while it was found only in 8% of U.S. patients (n = 100) from Georgia. There was significant linear correlation between spleen size and Hb levels and with serum immunoglobulins in the Nigerian group. However, serum complement levels (C3 and C4) were not affected by spleen size. In both groups, patients with splenomegaly had fewer circulating pitted red cells than their counterparts without splenomegaly. The mean ± SE of IgG‐specific malaria antibody titer among the Nigerian patients without palpable spleens was 9,386 ± 2,036; 9,334 ± 2,980 in those with spleens between 1 and 5 cm, 16,201 ± 4,502 in those with spleens between 6 and 10 cm, and 22,445 ± 8,456 in those with spleens above 10 cm. Coexistent α‐thalassemia did not influence the prevalence of splenomegaly among the Nigerian SS patients. This study provides additional evidence that malaria plays a significant role in the persistence of splenomegaly in African patients. © 1993 Wiley‐Liss, Inc.</description><subject>Adolescent</subject><subject>Adult</subject><subject>African SS patients</subject><subject>alpha-Thalassemia - genetics</subject><subject>Anemia, Sickle Cell - epidemiology</subject><subject>Anemias. Hemoglobinopathies</subject><subject>Antibodies, Protozoan - blood</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chromosome Mapping</subject><subject>Complement System Proteins - analysis</subject><subject>Diseases of red blood cells</subject><subject>Erythrocyte Count</subject><subject>Female</subject><subject>Georgia - epidemiology</subject><subject>Globins - genetics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Immunoglobulins - blood</subject><subject>Infant</subject><subject>malaria</subject><subject>Malaria - immunology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nigeria - epidemiology</subject><subject>splenomegaly</subject><subject>Splenomegaly - epidemiology</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDtvGzEQhAnDhiM_2nQBWBjpdOH7SHeCkNgxBKuQVR945DKhcy8fpRj696EgwXaXahfYb2cGg9BnSgpKCPtmn38XTHMiGOGUn6AJJUZNtZLsFE0IVzTvxHxCFyk9E0Kp0OQcnWvBtSFygparoQHocOxwiu5PA9hB02DbQRvtLZ737WBHu4l_AafN1kdIuA_4Mf6CMdoucx6vi1WBh8xAt0lX6CzYJsH1cV6i9Y_vT_P76WJ593M-W0wdy97TmjFhjDJCcMpq5UVJa8V1GUrvvAMhtZOW1M6UxBovuZRaByiDVwF8cJxfoq8H3WHsX7aQNlUb0z56Tt5vU1VKRQ0nZQaLA-jGPqURQjWMsbXjrqKk2jdY5Qar9wbzw5ej8rZuwb_hx8ry_eZ4t8nZJoy2czG9YUIxaeRexhyw19jA7j-m1ezh_kOEf8BOiDU</recordid><startdate>199303</startdate><enddate>199303</enddate><creator>Adekile, A. D.</creator><creator>McKie, K. M.</creator><creator>Adeodu, O. O.</creator><creator>Sulzer, A. J.</creator><creator>Liu, J.‐S.</creator><creator>McKie, V. C.</creator><creator>Kutlar, F.</creator><creator>Ramachandran, M.</creator><creator>Kaine, W.</creator><creator>Akenzua, G. I.</creator><creator>Okolo, A. A.</creator><creator>Asindi, A. A.</creator><creator>Obinyan, E. A.</creator><creator>Ogala, W. N.</creator><creator>Ibrahim, M.</creator><creator>Huisman, T. H. J.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199303</creationdate><title>Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients</title><author>Adekile, A. D. ; McKie, K. M. ; Adeodu, O. O. ; Sulzer, A. J. ; Liu, J.‐S. ; McKie, V. C. ; Kutlar, F. ; Ramachandran, M. ; Kaine, W. ; Akenzua, G. I. ; Okolo, A. A. ; Asindi, A. A. ; Obinyan, E. A. ; Ogala, W. N. ; Ibrahim, M. ; Huisman, T. H. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2843-b224996944312b6d471b6387f7dcdce458c5a0bc970a9d535588fe7fd6fedfc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>African SS patients</topic><topic>alpha-Thalassemia - genetics</topic><topic>Anemia, Sickle Cell - epidemiology</topic><topic>Anemias. Hemoglobinopathies</topic><topic>Antibodies, Protozoan - blood</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chromosome Mapping</topic><topic>Complement System Proteins - analysis</topic><topic>Diseases of red blood cells</topic><topic>Erythrocyte Count</topic><topic>Female</topic><topic>Georgia - epidemiology</topic><topic>Globins - genetics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Immunoglobulins - blood</topic><topic>Infant</topic><topic>malaria</topic><topic>Malaria - immunology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nigeria - epidemiology</topic><topic>splenomegaly</topic><topic>Splenomegaly - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adekile, A. D.</creatorcontrib><creatorcontrib>McKie, K. M.</creatorcontrib><creatorcontrib>Adeodu, O. O.</creatorcontrib><creatorcontrib>Sulzer, A. J.</creatorcontrib><creatorcontrib>Liu, J.‐S.</creatorcontrib><creatorcontrib>McKie, V. C.</creatorcontrib><creatorcontrib>Kutlar, F.</creatorcontrib><creatorcontrib>Ramachandran, M.</creatorcontrib><creatorcontrib>Kaine, W.</creatorcontrib><creatorcontrib>Akenzua, G. I.</creatorcontrib><creatorcontrib>Okolo, A. A.</creatorcontrib><creatorcontrib>Asindi, A. A.</creatorcontrib><creatorcontrib>Obinyan, E. A.</creatorcontrib><creatorcontrib>Ogala, W. N.</creatorcontrib><creatorcontrib>Ibrahim, M.</creatorcontrib><creatorcontrib>Huisman, T. H. J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adekile, A. D.</au><au>McKie, K. M.</au><au>Adeodu, O. O.</au><au>Sulzer, A. J.</au><au>Liu, J.‐S.</au><au>McKie, V. C.</au><au>Kutlar, F.</au><au>Ramachandran, M.</au><au>Kaine, W.</au><au>Akenzua, G. I.</au><au>Okolo, A. A.</au><au>Asindi, A. A.</au><au>Obinyan, E. A.</au><au>Ogala, W. N.</au><au>Ibrahim, M.</au><au>Huisman, T. H. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>1993-03</date><risdate>1993</risdate><volume>42</volume><issue>3</issue><spage>316</spage><epage>321</epage><pages>316-321</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><coden>AJHEDD</coden><abstract>Anecdotal reports have attributed persistent splenomegaly in African sickle cell anemia (SS) patients to the effects of malaria. However, no comparative studies of patients in malarial and nonmalarial regions have been conducted, and few studies of malaria antibody titers have been reported. In the present study, age‐ and sex‐matched Nigerian and U.S. steady‐state SS patients were compared. Splenomegaly was found in 22.3% of Nigerian patients (n = 310), while it was found only in 8% of U.S. patients (n = 100) from Georgia. There was significant linear correlation between spleen size and Hb levels and with serum immunoglobulins in the Nigerian group. However, serum complement levels (C3 and C4) were not affected by spleen size. In both groups, patients with splenomegaly had fewer circulating pitted red cells than their counterparts without splenomegaly. The mean ± SE of IgG‐specific malaria antibody titer among the Nigerian patients without palpable spleens was 9,386 ± 2,036; 9,334 ± 2,980 in those with spleens between 1 and 5 cm, 16,201 ± 4,502 in those with spleens between 6 and 10 cm, and 22,445 ± 8,456 in those with spleens above 10 cm. Coexistent α‐thalassemia did not influence the prevalence of splenomegaly among the Nigerian SS patients. This study provides additional evidence that malaria plays a significant role in the persistence of splenomegaly in African patients. © 1993 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8438905</pmid><doi>10.1002/ajh.2830420313</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0361-8609
ispartof American journal of hematology, 1993-03, Vol.42 (3), p.316-321
issn 0361-8609
1096-8652
language eng
recordid cdi_proquest_miscellaneous_75619307
source MEDLINE; Access via Wiley Online Library
subjects Adolescent
Adult
African SS patients
alpha-Thalassemia - genetics
Anemia, Sickle Cell - epidemiology
Anemias. Hemoglobinopathies
Antibodies, Protozoan - blood
Biological and medical sciences
Child
Child, Preschool
Chromosome Mapping
Complement System Proteins - analysis
Diseases of red blood cells
Erythrocyte Count
Female
Georgia - epidemiology
Globins - genetics
Hematologic and hematopoietic diseases
Humans
Immunoglobulins - blood
Infant
malaria
Malaria - immunology
Male
Medical sciences
Nigeria - epidemiology
splenomegaly
Splenomegaly - epidemiology
title Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A59%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spleen%20in%20sickle%20cell%20anemia:%20Comparative%20studies%20of%20Nigerian%20and%20U.S.%20patients&rft.jtitle=American%20journal%20of%20hematology&rft.au=Adekile,%20A.%20D.&rft.date=1993-03&rft.volume=42&rft.issue=3&rft.spage=316&rft.epage=321&rft.pages=316-321&rft.issn=0361-8609&rft.eissn=1096-8652&rft.coden=AJHEDD&rft_id=info:doi/10.1002/ajh.2830420313&rft_dat=%3Cproquest_cross%3E75619307%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75619307&rft_id=info:pmid/8438905&rfr_iscdi=true